Beta Drugs Limited (BETA.NS)
NSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹1,934.20 (-2.21%) as of
Key statistics
- Market cap
- 19.61B
- P/E (TTM)
- 28.49
- EPS (TTM)
- 67.90
- Dividend yield
- 0.00%
- 52-week range
- 990.10 – 2,807.90
- Beta
- -0.37
- Revenue (TTM)
- 4.1B
- Profit margin
- 11.11%
- Volume
- 60.45k
About Beta Drugs Limited
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Panchkula, India
- Employees
- 455
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.